poisar

Stocks · News reference

Baird Maintains Buy Rating on Twist Bioscience and Raises Price Target to $135

Fiscal.ai

Baird analyst Catherine Ramsey Schulte has maintained a Buy rating on Twist Bioscience while increasing the price target from $115 to $135.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading